TITLE

Innovations

AUTHOR(S)
O'Driscoll, Cath
PUB. DATE
August 2006
SOURCE
ICIS Chemical Business;8/28/2006, Vol. 1 Issue 32, p37
SOURCE TYPE
Trade Publication
DOC. TYPE
Article
ABSTRACT
The article offers news briefs on issues related to research and development. There has been a unanimous agreement between European Union ministers to the proposed implementation of research-based measures to combat terrorism. A bacteria capable of protecting the skin and body was discovered through a collaboration between BASF and OrganoBalance. The British National Institute for Health and Clinical Excellence refused to recommend Avastin and Erbitux drugs as treatment for advanced colon cancer.
ACCESSION #
22258708

 

Related Articles

  • NICE and new: appraising innovation. Ferner, Robin; Hughes, Dyfrig; Aronson, Jeffrey // BMJ: British Medical Journal (Overseas & Retired Doctors Edition;1/30/2010, Vol. 340 Issue 7740, p245 

    The authors explore the challenges of encouraging innovation while ensuring the clinical benefits of new drugs. They discuss how innovativeness and usefulness might be defined in health care and how the British National Institute for Health and Clinical Excellence and other organizations might...

  • Sir Michael Rawlins.  // Nature Reviews Drug Discovery;Apr2006, Vol. 5 Issue 4, p276 

    The article presents an interview with Michael Rawlins, chairman of the British National Institute for Health and Clinical Excellence (NICE). In the interview, Rawlins talked about the role and function of NICE. He also talked about the aim of the Single Technology Appraisal process and the...

  • UK's Cancer Drugs Fund boss regrets its establishment.  // PharmacoEconomics & Outcomes News;Jan2015, Vol. 720 Issue 1, p5 

    The article reports that Peter Clarke, chairman and oncology consultant at Cancer Drugs Fund (CDF) of England, regretted the establishment of the CDF for it undermined the function of the National Institute for Clinical Excellence (NICE) to approve cost-effective interventions. Topics discussed...

  • Can waifarin alternatives fulfil their promise? Stirling, Alisdair // Pulse;Oct2013, p21 

    The article reports on the potential of warfarin alternatives to meet its potential, focusing on cost concerns and clinical uncertainty of new oral anticoagulants (NOACs). It discusses the developments of NOACS to be approved by British National Institute for Health and Care Excellence (NICE),...

  • Ivabradine in heart failure: NICE guidance. Hardman, Suzanna M. C. // Heart;Jan2014, Vol. 100 Issue 2, p93 

    The author reflects on the 2010 Comprehensive Heart Failure (CHF) Guideline from Great Britain's National Institute for Health and Clinical Excellence Single Technology Appraisal (NICE) regarding the use of novel medication ivabradine in treatment of heart diseases. He states that ivabradine is...

  • News & Views. Etherington, Clare; van Hecke, Oliver // InnovAiT;Jun2011, Vol. 4 Issue 6, p316 

    The article presents various insights on topics related to general practice (GP). An author comments on a King's Fund study which has discovered that GP care has wide variations in terms of prescribing, referral, and diagnosis. Another author offers idea on the Great Britain National Institute...

  • Summary of: Antibiotic prophylaxis in dentistry: part II. A qualitative study of patient perspectives and understanding of the NICE guideline. Gibson, B. // British Dental Journal;7/1/2011, Vol. 211 Issue 1, p26 

    Background The National Institute for Health and Clinical Excellence (NICE) recommendations in 2008 for antibiotic prophylaxis before dental treatment contradict previous practice. There is a potential difficulty in explaining the new guidance to patients who have long believed that they must...

  • Drug combination can protect bones.  // GP: General Practitioner;6/19/2009, p10 

    The article reports on the significance of combining rosiglitazone and metformin in protecting bones. It notes on the findings of the previous research regarding the risks of rosiglitazone which could lead to bone loss which prompted the National Institute for Health and Clinical Excellence...

  • Adjunctive pharmacotherapies for intermittent claudication--NICE guidance. Shalhoub, Joseph; Davies, Alun H. // Heart;Feb2012, Vol. 98 Issue 3, p244 

    The article focuses on the technology appraisal guidance offered by the National Institute for Health and Clinical Excellence (NICE) on available adjunctive pharmacotherapies for people with peripheral arterial disease and intermittent claudication. It notes that the therapies considered the...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics